Abstract:Background Systemic sclerosis (SSc) is a connective tissue disease characterized by autoimmunity, small vessel vasculopathy and excessive collagen deposition in the skin and internal organs. Pulmonary involvement is responsible for reducing the functional capacity to exercise and represents the main cause of death. The six-minute walk test (6MWT) is a simple, non-invasive, easy-to-perform, and reliable submaximal aerobic exercise test that can used in patients with advanced lung disease. Patients with SSc often have not only lung disease, but combinations of cardiopulmonary involvement, skin fibrosis, musculoskeletal damage, and joint disease, which can confound the 6MWT interpretation. As it is an independent predictor of SSc-related mortality, the 6MWT is a potentially useful tool in the assessment of outcomes along with pulmonary function tests (PFTs) and computed tomography. Currently, there is a huge concern about the need for early screening, search for new treatments and closer monitoring of patients with diffuse cutaneous systemic sclerosis-associated interstitial lung disease (dcSSs-ILD) before irreversible deterioration of lung function occurs. Objectives To build a predictive model for the six-minute walk distance (6MWD) in women with dcSSs-ILD without pulmonary arterial hypertension. Methods This is a cross-sectional study in which 69 women with dcSSs-ILD underwent the 6MWT, Health Assessment Questionnaire-Disability Index (HAQ-DI), PFTs (including spirometry, measurement of pulmonary diffusion capacity for carbon monoxide-DLCO and measurement of respiratory muscle strength), handgrip strength (HGS) and quadriceps strength (QS). Results The mean 6MWD was 447 ± 78 m, with 43.5% of the participants not reaching 80% of the predicted value. The 6MWT was positively correlated with HR (r = 0.418, P = 0.0004), forced vital capacity (r = 0.306, P = 0.011), DLCO (r = 0.360, P = 0.002), maximal inspiratory pressure (r = 0.268 , P = 0.029), and maximal expiratory pressure (MEP, r = 0.288, P = 0.019) and negatively with age (r = -0.378, P = 0.001), body mass index (BMI) r = -0.248, P = 0.039) and HAQ-DI (r = -0.438, P = 0.0001). In the multiple linear regression analysis, QS, BMI, DLCO, age and MEP explained 72% of the 6MWD variability. Conclusion In patients with dcSSs-ILD, alongside reduced pulmonary diffusion, deterioration in respiratory and peripheral muscle strength negatively impact performance during the 6MWT. Furthermore, the greater the age and BMI, the lower the 6MWD. Our results are promising and may become a contribution to future investigations aimed at new pharmacological therapies for dcSSs-ILD. Implications These findings may help the growing number of randomized controlled trials that have emerged in search of disease-modifying therapies for dcSSs-ILD, with the aim of incorporating the 6MWD as a clinical outcome measure.

Characteristics of skeletal muscle strength in subjects with interstitial lung disease

Article Risk of Subsequent Gastrointestinal Disease Assessed by Skeletal Muscle Strength and Mass in a Cohort

Distribution of Muscle Weakness in Patients With Stable Chronic Obstructive Pulmonary Disease

Ultrasound assessment of diaphragm and quadriceps muscles and its relationship with handgrip and respiratory muscle strength in patients with systemic sclerosis: a cross-sectional study

Nutritional status and quality of life in interstitial lung disease: a prospective cohort study

Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease

The Association between the Respiratory System and Upper Limb Strength in Males with Duchenne Muscular Dystrophy: A New Field for Intervention?

Lower Limb Strength Profile in Elderly with Different Pathologies: Comparisons with Healthy Subjects

Alterations in Respiratory and Limb Muscle Strength and Size in Patients With Sepsis Who Are Mechanically Ventilated

Clinical profiles and treatment outcomes of outpatients with interstitial lung disease and mechanic’s hands: A retrospective and observational cohort

Muscle Strength Comparison in Immune-Mediated Rheumatic Disease vs Healthy Adults: A Meta-Analysis

Impact of interstitial lung disease on left ventricular myocardial function

Differences of ventilatory muscle recruitment and work of breathing in COPD and interstitial lung disease during exercise: a comprehensive evaluation

Control of breathing in patients with limb girdle dystrophy: a controlled study

Relationship between peripheral muscle strength, exercise capacity and body composition in children and adolescents with cystic fibrosis

Correlation of functional data with diaphragm measurements evaluated by ultrasound in patients with Interstitial Lung Disease

Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness

Impaired muscle parameters in adults with mild to severe types of osteogenesis imperfecta: a cross-sectional study

VARIABILITY OF 6-MINUTE WALK DISTANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

Evaluating disease status in idiopathic inflammatory myopathies with quantitative muscle ultrasound

Comparison of muscle oxygenation, dyspnea, oxygen uptake and energy expenditure during upper and lower limb cardiopulmonary exercise test in patients with ILD